» Articles » PMID: 22981791

Deficient Antiviral Immune Responses in Childhood: Distinct Roles of Atopy and Asthma

Overview
Date 2012 Sep 18
PMID 22981791
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Impaired immune response to viral infections in atopic asthmatic patients has been recently reported and debated. Whether this condition is present in childhood and whether it is affected by atopy per se deserves further investigation.

Objective: We sought to investigate airway interferon production in response to rhinovirus infection in children who are asthmatic, atopic, or both and its correlation with the airway inflammatory profile.

Methods: Bronchial biopsy specimens and epithelial cells were obtained from 47 children (mean age, 5 ± 0.5 years) undergoing bronchoscopy. The study population included asthmatic children who were either atopic or nonatopic, atopic children without asthma, and children without atopy or asthma. Rhinovirus type 16 induction of IFN-λ and IFN-β mRNA and protein levels was assessed in bronchial epithelial cell cultures. The immunoinflammatory profile was evaluated by means of immunohistochemistry in bronchial biopsy specimens.

Results: Rhinovirus type 16-induced interferon production was significantly reduced in atopic asthmatic, nonatopic asthmatic, and atopic nonasthmatic children compared with that seen in nonatopic nonasthmatic children (all P < .05). Increased rhinovirus viral RNA levels paralleled this deficient interferon induction. Additionally, IFN-λ and IFN-β induction correlated inversely with the airway T(H)2 immunopathologic profile (eosinophilia and IL-4 positivity: P < .05 and r = -0.38 and P < .05 and r = -0.58, respectively) and with epithelial damage (P < .05 and r = -0.55). Furthermore, total serum IgE levels correlated negatively with rhinovirus-induced IFN-λ mRNA levels (P < .05 and r = -0.41) and positively with rhinovirus viral RNA levels (P < .05 and r = 0.44).

Conclusions: Deficient interferon responses to rhinovirus infection are present in childhood in asthmatic subjects irrespective of their atopic status and in atopic patients without asthma. These findings suggest that deficient immune responses to viral infections are not limited to patients with atopic asthma but are present in those with other T(H)2-oriented conditions.

Citing Articles

Inhaled magnesium versus inhaled salbutamol in rescue treatment for moderate and severe asthma exacerbations in pediatric patients.

Debiazzi M, Bonatto R, Campos F, Martin J, Fioretto J, Hansen M J Pediatr (Rio J). 2024; 100(5):539-543.

PMID: 38693043 PMC: 11361882. DOI: 10.1016/j.jped.2024.03.012.


A single dose of angiotensin-(1-7) resolves eosinophilic inflammation and protects the lungs from a secondary inflammatory challenge.

Magalhaes G, Gregorio J, Beltrami V, Felix F, Oliveira-Campos L, Bonilha C Inflamm Res. 2024; 73(6):1019-1031.

PMID: 38656426 DOI: 10.1007/s00011-024-01880-x.


Airway epithelial cell response to RSV is mostly impaired in goblet and multiciliated cells in asthma.

Gay A, Banchero M, Carpaij O, Kole T, Apperloo L, van Gosliga D Thorax. 2024; 79(9):811-821.

PMID: 38373824 PMC: 11347251. DOI: 10.1136/thorax-2023-220230.


The functional role of CST1 and CCL26 in asthma development.

Hoyer A, Chakraborty S, Lilienthal I, Konradsen J, Katayama S, Soderhall C Immun Inflamm Dis. 2024; 12(1):e1162.

PMID: 38270326 PMC: 10797655. DOI: 10.1002/iid3.1162.


Membrane lipid composition of bronchial epithelial cells influences antiviral responses during rhinovirus infection.

Panchal M, Swindle E, Pell T, Rowan W, Childs C, Thompson J Tissue Barriers. 2024; 12(4):2300580.

PMID: 38179897 PMC: 11583602. DOI: 10.1080/21688370.2023.2300580.